2,125 results on '"Pileri Stefano A"'
Search Results
2. Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
3. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
4. Correction to: Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
5. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis
6. Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence
7. Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
8. Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature
9. Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report
10. EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda
11. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
12. A Rare Case of BIA-ALCL Mass Associated with Mastectomy Skin Flap Erythema After Immunization with COVID-19
13. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities
14. Extranodal T- and NK-cell lymphomas
15. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis
16. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
17. Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
18. Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
19. Clonal T-cell proliferations occasionally occur in Kikuchi-Fujimoto disease
20. Histiocytic and dendritic cell neoplasms
21. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
22. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
23. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
24. Genetic and phenotypic attributes of splenic marginal zone lymphoma
25. Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
26. A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
27. Histiocytic Neoplasma
28. Myeloid Sarcoma
29. Targeting CD30 in Patients with Hodgkin Lymphoma
30. Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma
31. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas
32. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
33. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
34. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
35. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
36. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
37. CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma
38. Targeted DNA Damage Boost with Loncastuximab Tesirine in Combination with PARP Inhibitors in Diffuse Large B-Cell Lymphoma
39. The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib
40. Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma
41. Targeting CD30 in Patients with Hodgkin Lymphoma
42. Novel markers in pediatric-type follicular lymphoma
43. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas
44. Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel
45. S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME
46. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis
47. Lymphoproliferative Disorders Associated with Sjögren Syndrome
48. Pathology of nodal marginal zone lymphomas
49. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
50. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.